Nicotine receptor partial agonists for smoking cessation
about
Efficacy of pharmacotherapies for short-term smoking abstinance: a systematic review and meta-analysis.Nicotine receptor partial agonists for smoking cessationExercise interventions for smoking cessationNicotine receptor partial agonists for smoking cessationBehavioural interventions as adjuncts to pharmacotherapy for smoking cessationNicotine receptor partial agonists for smoking cessationInterventions for preoperative smoking cessationCombined pharmacotherapy and behavioural interventions for smoking cessationInterventions for promoting smoking cessation during pregnancyMotivational interviewing for smoking cessationInterventions for preventing weight gain after smoking cessationAntidepressants for smoking cessationExperiences of tobacco smoking and quitting in smokers with and without chronic obstructive pulmonary disease-a qualitative analysis“Hike up yer skirt, and quit.” what motivates and supports smoking cessation in builders and renovatorsConstitutional mechanisms of vulnerability and resilience to nicotine dependenceThe smoking cessation drug varenicline improves deficient P20-N40 inhibition in DBA/2 mice.Modulation of ethanol consumption by genetic and pharmacological manipulation of nicotinic acetylcholine receptors in mice.Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey.Smoking outcome by psychiatric history after behavioral and varenicline treatment.Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence.Behavioral counseling and varenicline treatment for smoking cessation.Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trialHow confident should we be that smoking cessation treatments work?Management of Crohn's disease in smokers: is an alternative approach necessary?Smoking cessation interventions for patients with depression: a systematic review and meta-analysisAnxiolytics for smoking cessation.Pulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era.Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence.The nicotinic acetylcholine receptor partial agonist varenicline increases the ataxic and sedative-hypnotic effects of acute ethanol administration in C57BL/6J mice.Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial.Update in addiction medicine for the generalistPreclinical Pharmacology, Efficacy and Safety of Varenicline in Smoking Cessation and Clinical Utility in High Risk Patients.Socioeconomic variations in access to smoking cessation interventions in UK primary care: insights using the Mosaic classification in a large dataset of primary care records.Adherence to varenicline in the COMPASS smoking cessation intervention trial.Repeated aripiprazole administration attenuates cocaine seeking in a rat model of relapseClinician's guide to the updated ABCs of cardiovascular disease prevention.Combination pharmacotherapy for stopping smoking: what advantages does it offer?Treatment of tobacco dependence.Protein kinase C epsilon modulates nicotine consumption and dopamine reward signals in the nucleus accumbens.Efficacy of varenicline to prompt quit attempts in smokers not currently trying to quit: a randomized placebo-controlled trial
P2860
Q21093272-23017429-95A5-4482-9651-3B84D8C4AADCQ24185773-A14A7DDD-86B3-446E-9A18-86611CAE8895Q24194247-F366671A-92E7-4317-821C-E685F34A2472Q24200322-AE92E2AD-BDDD-4568-9A08-8BE57D62EF8CQ24203802-8A656C54-0ABD-48EF-8BA1-51E3A197EB36Q24235456-FBAC8B13-7833-4270-A4F2-06C242A235E2Q24236778-B0FD2EEF-D819-4827-B4A3-A535CAB91CDFQ24239883-B3C9307F-8A94-4A63-B3A9-098D7739DDEBQ24240117-22031AF3-C68E-42D8-8BBC-42E9E4754C8CQ24240806-21428233-A7F6-4597-AE85-90867CC582D6Q24241751-92FDEA5D-317D-45BF-8FBA-2B5AF34FFA2FQ24246426-E06E03B6-EA65-431F-93D3-992E769726B1Q27314117-52E764BA-9AB6-435C-955F-430A5456A5B8Q28397312-1A0C79CD-32F8-4E79-AB88-790C96BE811AQ30365559-30285E53-B7DD-4E6C-9331-DFDA681B9BACQ30461965-17062E0C-DD23-46DA-A6F4-8605CF48B45FQ30475871-627F8C44-153B-4103-885A-647AB2CE3215Q33767740-89BE49AC-848F-495F-87F4-4B0F79E4DB1CQ33812071-6136FF68-82E7-435C-A0C1-3E14F3891E45Q33870433-A4751CCE-66A8-4471-B532-71CAB21777FCQ33887611-96B07803-7F45-45CF-B1EB-4BFA6BEDD4F5Q33897433-946403FF-F159-4EE5-8F12-07BD63D1F05EQ33925108-71C4E5EE-55C4-46A4-8D52-DA3FE74BE0B5Q34028909-49F55B13-5804-43D4-AF8F-DB3B39D8AF2FQ34061804-E64DC3CB-677E-4703-83DD-930041BA5415Q34062467-E2175BE9-7F7E-4455-91B8-51D16D0B5DB5Q34172133-63A3416E-EC23-4536-9F64-8007046C980BQ34197010-0FB52508-2750-4B2B-A097-99D7BAC13372Q34336464-12E68258-31B7-4A42-8409-3EE6EB028DEDQ34383047-24E7145A-7551-41C1-94A6-9665392ACB09Q34506003-94E19A24-F22E-4D75-B008-37C6AFA4F732Q34526371-F57269F3-026B-4176-8E58-F35AD940972FQ34759494-D2FF8E7D-E86B-43AA-8699-B6DA7124EE29Q34859460-4D43664D-EBBE-4190-B7A7-9932BC9A9C0FQ35062881-B58A4C84-A86B-4B95-9E63-ECEFFD7704F6Q35070830-77CDEDAB-6406-4CB3-94A5-7855FEDCC1F8Q35188753-E0F22CDC-BBB3-4ED6-AEF8-805632A19739Q35199252-EFE4F098-B6CB-4AB7-BE33-5D0CC2CC64CFQ35229091-154E341E-17D3-40DD-96FE-22BED82FE400Q35557088-9EF9D268-1877-4493-BBA2-10514B6A060D
P2860
Nicotine receptor partial agonists for smoking cessation
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Nicotine receptor partial agonists for smoking cessation
@ast
Nicotine receptor partial agonists for smoking cessation
@en
Nicotine receptor partial agonists for smoking cessation
@en-gb
Nicotine receptor partial agonists for smoking cessation
@nl
type
label
Nicotine receptor partial agonists for smoking cessation
@ast
Nicotine receptor partial agonists for smoking cessation
@en
Nicotine receptor partial agonists for smoking cessation
@en-gb
Nicotine receptor partial agonists for smoking cessation
@nl
prefLabel
Nicotine receptor partial agonists for smoking cessation
@ast
Nicotine receptor partial agonists for smoking cessation
@en
Nicotine receptor partial agonists for smoking cessation
@en-gb
Nicotine receptor partial agonists for smoking cessation
@nl
P2093
P1476
Nicotine receptor partial agonists for smoking cessation
@en
P2093
Kate Cahill
Lindsay F Stead
Tim Lancaster
P356
10.1002/14651858.CD006103.PUB3
P577
2008-07-16T00:00:00Z